Literature DB >> 15983686

Risk factors for hepatocellular carcinoma in Southern Iran.

Eskandar Hajiani1, Rahim Masjedizadeh, Jalal Hashemi, Mehrdad Azmi, Tahereh Rajabi.   

Abstract

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Its etiology and incidence differ according to geographic area. In the present study, we sought to identify risk factors for HCC among a group of patients with HCC in Southern Iran.
METHODS: During a 5-year period we retrospectively studied the characteristics of 71 HCC patients at Ahwaz Jundishapur University Hospital, Iran from February 1999 to August 2004. Blood samples and questionnaire data obtained from 71 (45 male and 26 female) incident cases of HCC, were pathologically diagnosed. Sera were tested for hepatitis B surface antigen and antibodies to hepatitis B core antigen, anti-hepatitis C virus and serum ferritin, iron and alfa fetoprotein (AFP), by enzyme immunoassays and cuper study.
RESULTS: In 46.5% (33/71) of patients there was a history of chronic liver disease, and in 30 (42%) patients liver cirrhosis was documented. Of the 71 patients, 37 (52.1%) had hepatitis B, 6 (8.5%) had hepatitis C, and 2 (2.8%) had a history of excess alcohol intake. Of the 2 patients with a history of heavy alcohol intake, one had concomitant chronic viral hepatitis infection, and alcohol alone was the etiology of HCC in only one case (1.40%). No etiologic cause was identified in 23 cases (32.4%), there were 2 cases of diabetes mellitus. The value of AFP of >20 ng/ml was found in 29 cases (41%), varying from 24 ng/ml to 364 ng/ml (average 74.6 ng/ml).
CONCLUSIONS: In Southern Iran, the predominant etiology of HCC was hepatitis B, hepatitis C, but alcohol and metabolic diseases were only found in rare cases. Cryptogenic cases may be found in one fifth of patients hence, the contribution of virus infection, may have been underestimated in this area, which is based on serological testing only.

Entities:  

Mesh:

Year:  2005        PMID: 15983686

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  12 in total

1.  Wide Sexual Dimorphism of Hepatocellular Carcinoma Presentation in Algeria.

Authors:  Yazid Chikhi; Salima Cheraitia; Rachid Ould Gougam; Fadila Lounes; Chahrazed Zemmouchi; Nassila Belal; Maroua Bendaoud; Sonia Ait Younes; Aicha Bensalem; Saadi Berkane; Hocine Asselah; Pascal Pineau; Mustapha Lahcene
Journal:  Gastrointest Tumors       Date:  2019-08-30

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Hepatocellular carcinoma in Asia: Prevention strategy and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Afsaneh Sharifian; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-06-28

4.  First multicenter study for risk factors for hepatocellular carcinoma development in North Africa.

Authors:  Olfa Bahri; Sayeh Ezzikouri; Nissaf Ben Alaya-Bouafif; Fella Iguer; Abdallah Essaid El Feydi; Hafedh Mestiri; Moustapha Benazzouz; Tahar Khalfallah; Rajaa Afifi; Latifa Elkihal; Salah Berkane; Agnes Marchio; Nabil Debzi; Anne Dejean; Pascal Pineau; Hinda Triki; Soumaya Benjelloun
Journal:  World J Hepatol       Date:  2011-01-27

5.  Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Agostino Colli; Tin Nadarevic; Damir Miletic; Vanja Giljaca; Mirella Fraquelli; Davor Štimac; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

6.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

7.  Incidence of hepatocellular carcinoma in southeast iran.

Authors:  Sodaif Darvish Moghaddam; Ali Akbar Haghdoost; Seyed Hamed Hoseini; Rashid Ramazani; Mohammad Rezazadehkermani
Journal:  Hepat Mon       Date:  2010-12-01       Impact factor: 0.660

8.  Transcatheter arterial chemoembolization therapy for patients with unresectable hepatocellular carcinoma.

Authors:  Kavous Firouznia; Hossein Ghanaati; Seyed Moayed Alavian; Payam Azadeh; Mohsen Nasiri Toosi; Arya Haj Mirzaian; Safa Najafi; Madjid Shakiba; Amir Hossein Jalali
Journal:  Hepat Mon       Date:  2014-12-28       Impact factor: 0.660

9.  Mortality trends of gastrointestinal cancers in Iranian population.

Authors:  Mohamad Amin Pourhoseingholi; Zeinab Fazeli; Sara Ashtari; Fatemeh Sadat Fazeli Bavand-Pour
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

Review 10.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Authors:  Seyed Moayed Alavian; Hossein Haghbin
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.